Literature DB >> 12161277

Signaling of gp34 (OX40 ligand) induces vascular endothelial cells to produce a CC chemokine RANTES/CCL5.

Ai Kotani1, Toshiyuki Hori, Yumi Matsumura, Takashi Uchiyama.   

Abstract

We previously showed that gp34 (OX40 ligand) expressed on vascular endothelial cells is not only involved in adhesion between activated T cells and endothelial cells but also by itself able to transmit intracellular signals leading to expression of c-fos and c-jun mRNA upon OX40 binding. In the present study, we searched for genes that were induced or upregulated by gp34 signaling in human umbilical vein endothelial cells (HUVECs) to define its downstream biological events. HUVECs expressing high levels of gp34 were stimulated with recombinant soluble OX40 or mock control and subjected to analysis using cDNA expression arrays. We found that a CC chemokine RANTES (regulated upon activation, normal T cell expressed and secreted)/CCL5 is one of such inducible genes. Reverse transcriptase-PCR analysis showed that expression of RANTES mRNA was induced after incubation with soluble OX40 and this induction was inhibited by anti-gp34 mAb. We could detect expression of intracellular RANTES protein by flow cytometry in HUVECs stimulated with soluble OX40 as well as fixed OX40 transfectant cells but not those stimulated with mock supernatants or mock transfectant cells. Again, this induction of RANTES protein was inhibited by anti-gp34 mAb. These results clearly indicate that gp34 signaling induces expression of RANTES at both mRNA and protein levels in HUVECs and suggest a possible link between the OX40/gp34 system and RANTES during the process of T cell adhesion to endothelial cells and subsequent extravasation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161277     DOI: 10.1016/s0165-2478(02)00082-2

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  18 in total

1.  The role of CCL5 in the ability of adipose tissue-derived mesenchymal stem cells to support repair of ischemic regions.

Authors:  Kenichi Kimura; Masumi Nagano; Georgina Salazar; Toshiharu Yamashita; Ikki Tsuboi; Hajime Mishima; Shonosuke Matsushita; Fujio Sato; Kenji Yamagata; Osamu Ohneda
Journal:  Stem Cells Dev       Date:  2013-12-14       Impact factor: 3.272

Review 2.  Control of immunity by the TNFR-related molecule OX40 (CD134).

Authors:  Michael Croft
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 3.  Roles of OX40 in the pathogenesis and the control of diseases.

Authors:  Toshiyuki Hori
Journal:  Int J Hematol       Date:  2006-01       Impact factor: 2.490

4.  Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis.

Authors:  Georgia Fousteri; Amy Dave; Bret Morin; Shaida Omid; Michael Croft; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2011-02-17       Impact factor: 7.094

5.  Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage.

Authors:  Jean-Pierre Louboutin; Alena Chekmasova; Elena Marusich; Lokesh Agrawal; David S Strayer
Journal:  FASEB J       Date:  2010-10-12       Impact factor: 5.191

6.  Technical advance: soluble OX40 molecule mimics regulatory T cell modulatory activity on FcεRI-dependent mast cell degranulation.

Authors:  Riccardo Sibilano; Giorgia Gri; Barbara Frossi; Claudio Tripodo; Ryo Suzuki; Juan Rivera; Andrew S MacDonald; Carlo E Pucillo
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

Review 7.  Genetic and genomic insights into the molecular basis of atherosclerosis.

Authors:  Yaoyu Chen; Jarod Rollins; Beverly Paigen; Xiaosong Wang
Journal:  Cell Metab       Date:  2007-09       Impact factor: 27.287

8.  Genetic variants of TNFSF4 and risk for carotid artery disease and stroke.

Authors:  P S Olofsson; L A Söderström; C Jern; A Sirsjö; M Ria; E Sundler; U de Faire; P G Wiklund; J Ohrvik; U Hedin; G Paulsson-Berne; A Hamsten; P Eriksson; G K Hansson
Journal:  J Mol Med (Berl)       Date:  2008-11-08       Impact factor: 4.599

9.  OX40 expression in neutrophils promotes hepatic ischemia/reperfusion injury.

Authors:  Hua Jin; Chunpan Zhang; Chengyang Sun; Xinyan Zhao; Dan Tian; Wen Shi; Yue Tian; Kai Liu; Guangyong Sun; Hufeng Xu; Dong Zhang
Journal:  JCI Insight       Date:  2019-11-01

Review 10.  OX40, OX40L and Autoimmunity: a Comprehensive Review.

Authors:  Gwilym J Webb; Gideon M Hirschfield; Peter J L Lane
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.